Abbott Laboratories (ABT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Abbott Laboratories

    NYSE: ABT · Real-Time Price · USD
    132.47
    0.29 (0.22%)
    At close: Sep 04, 2025, 3:47 PM

    Abbott Laboratories Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 41.95B 40.11B 43.65B 43.08B
    Cost of Revenue
    		 20.63B 20.07B 21.33B 19.86B
    Gross Profit
    		 21.32B 20.04B 22.32B 23.21B
    Operating Income
    		 6.83B 6.43B 8.36B 9.2B
    Interest Income
    		 344M 385M 183M 43M
    Pretax Income
    		 7.01B 6.66B 8.31B 8.21B
    Net Income
    		 13.4B 5.72B 6.93B 7.07B
    Selling & General & Admin
    		 11.65B 10.88B 11.11B 11.28B
    Research & Development
    		 2.82B 2.72B 2.85B 2.74B
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 14.47B 13.6B 13.96B 14.01B
    Interest Expense
    		 603M 698M 315M 410M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 35.1B 33.67B 35.29B 33.88B
    Income Tax Expense
    		 -6.39B 941M 1.37B 1.14B
    Shares Outstanding (Basic)
    		 1.73B 1.73B 1.75B 1.77B
    Shares Outstanding (Diluted)
    		 1.75B 1.75B 1.76B 1.79B
    EPS (Basic)
    		 7.67 3.30 3.94 3.97
    EPS (Diluted)
    		 7.64 3.27 3.91 3.94
    EBITDA
    		 10.83B 10.61B 11.89B 12.16B
    EBIT
    		 7.62B 7.36B 8.62B 8.62B
    Depreciation & Amortization
    		 3.22B 3.24B 3.27B 3.54B

    Add to Watchlist